An NYU study that involved 100 mg of zinc sulfate added to hydroxychloroquine, shows that people given that combo, with azithromycin, are 45 percent less likely to die from Covid-19, 46 percent less likely to be transferred to intensive care, and 38 percent likely to be put on a ventilator. But once a patient is transferred to intensive care, the odds of survival go way down even with the HCQ cocktail.
Spectrum's 24-hour New York City cable channel, NY-1, has been one of the few outlets following hydroxychloroquine (two articles so far on the Langone trials). And more studies will be coming out of NYU — including double-blind and randomized, as well as the University of South Dakota, and Cedars-Sinai in Los Angeles.